2039 completed, 763 unknown, 293 terminated, 264 recruiting. 3673 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3673 | Completed 2039, Unknown 763, Terminated 293, Recruiting 264, Not yet recruiting 122, Withdrawn 121, Active not recruiting 48, Enrolling by invitation 17, Suspended 6 |
Follow Vascular Diseases: new trials by email Literature Review of Vascular Diseases trials Research Report on Vascular Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety And Field Evaluation of Plasma Lyophilized for Acute and Surgical Management Applications Freeze-Dried Plasma, Conventional Plasma - Thromboembolic Event, FDP | Phase 4 | Not yet recruiting | Teleflex | 867 | 2027-10-01 | 2026-09-30 |
| OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation Oral anticoagulation, Single antiplatelet therapy - Atrial Fibrillation (AF), Coronary Artery Disease | Phase 4 | Not yet recruiting | Ewha Womans University Mokdong Hospital | 2 | 2027-03-01 | 2026-03-27 |
| BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases. teclistamab OR talquetamab OR elranatamab OR linvoseltamab, BTK inhibitors (ibrutinib and zanubrutinib) - Waldenstrom Macroglobulinaemia, Multiple Myeloma | Phase 4 | Not yet recruiting | Anne Louise Tølbøll Sørensen | 400 | 2027-03-01 | 2026-03-16 |
| Spontaneous Coronary Artery Dissection - AntipLatelet Therapy Intensity in Guided coNservative Management (SCAD-ALIGN) Trial Acetylsalicylic acid ASA, ASA plus Clopidogrel - SCAD, ACS (Acute Coronary Syndrome) | Phase 4 | Not yet recruiting | Universitätsklinikum Hamburg-Eppendorf | 3518 | 2027-03-01 | 2026-10-16 |
| A Trial Assessing the Effectiveness of Evolocumab in Reducing the Plaque Burden in Participants With Subclinical Atheroma Evolocumab, Routine Lipid Management, Autoinjector - Coronary Artery Disease, Hypercholesterolemia | Phase 4 | Not yet recruiting | Amgen | 308 | 2027-01-31 | 2026-09-21 |
| RESCUE: PCSK9 Inhibitors for Carotid Vulnerable Plaque Remodeling Intervention 1, Intervention 3, Intervention 2 - Atherosclerosis Cerebral, Carotid Plaque | Phase 4 | Not yet recruiting | Keqiang Zhao | 120 | 2027-01-01 | 2026-09-15 |
| SPIRO-First: A Pragmatic Primary Care-Embedded Pilot Trial of Renin-Guided First-Line Antihypertensive Therapy Spironolactone (drug), Candesartan 8mg, Hydrochlorothiazide (HCTZ) 25 milligrams. - Hypertension | Phase 4 | Not yet recruiting | Ottawa Hospital Research Institute | 30 | 2027-01-01 | 2026-10-14 |
| Lumbar Drain With Intrathecal Nicardipine in Aneurysmal Subarachnoid Hemorrhage Normal Saline, Nicardipine - Subarachnoid Hemorrhage | Phase 4 | Not yet recruiting | Wake Forest University Health Sciences | 214 | 2027-01-01 | 2026-10-01 |
| Anti-inflammatory and Anti-thrombotic Therapy With colcHicine and Low Dose Rivaroxaban for Major Adverse Cardiovascular Events Reduction in Ischemic Stroke Rivaroxaban 2.5 Mg Oral Tablet, Colchicine 0.5 MG, Placebo Rivaroxaban - Ischemic Stroke | Phase 4 | Not yet recruiting | Brazilian Clinical Research Institute | 4500 | 2027-01-01 | 2026-10-30 |
| OB VEGA-Phenylephrine vs Norepinephrine Outcomes Phenylephrine, Norepinephrine - Hypotension During Surgery, Cesarean Birth | Phase 4 | Not yet recruiting | Wake Forest University Health Sciences | 1500 | 2027-01-01 | 2026-10-28 |
| Ceasing Alpha-blockers Early After Resection of the Prostate (The CLEAR Trial) Tamsulosin hydrochloride 0.2 mg, Placebo - Benign Prostatic Hyperplasia | Phase 4 | Not yet recruiting | Shanghai East Hospital | 400 | 2026-12-01 | 2026-09-29 |
| Capital Offload-Shock Immediate renal replacement therapy - Hypervolemia, Cardiogenic Shock | Phase 4 | Not yet recruiting | Ottawa Heart Institute Research Corporation | 456 | 2026-12-01 | 2026-10-30 |
| Efficacy and Safety of Methylprednisolone After Flow-Diverter Stent Implantation in Unruptured Intracranial Aneurysms Methylprednisolone (Injectable Form), Placebo Injection - Unruptured Intracranial Aneurysms, Cerebrovascular Event | Phase 4 | Not yet recruiting | Duan Chuanzhi | 864 | 2026-11-30 | 2026-10-26 |
| A Clinical Study of MK-7962 in Chinese Participants With Pulmonary Arterial Hypertension (MK-7962-022) Sotatercept - Hypertension, Pulmonary | Phase 4 | Not yet recruiting | Merck Sharp & Dohme LLC | 40 | 2026-11-30 | 2026-10-28 |
| Edoxaban Versus Apixaban in Cancer-Associated Venous Thromboembolism edoxaban, Apixaban - Venous Thromboembolism, Active Cancer | Phase 4 | Not yet recruiting | Samsung Medical Center | 2300 | 2026-11-01 | 2026-10-01 |
| Lumbrokinase vs Placebo in Moderate-to-Severe Ischemic Stroke Lumbrokinase, Lumbrokinase Placebo - Ischemic Stroke, Acute | Phase 4 | Not yet recruiting | Xinqiao Hospital of Chongqing | 1196 | 2026-11-01 | 2026-08-13 |
| Emerging Indications for Hyperbaric Oxygen Treatment Hyperbaric oxygen treatment (HBOT), 100% Oxygen - Post-COVID-19 Condition, Ulcerative Colitis | Phase 4 | Not yet recruiting | Jay C. Buckey Jr. | 100 | 2026-11-01 | 2026-09-09 |
| Superficial Parasternal Block Combined With Rectus Sheath Block for Open Cardiac Surgery Parasternal and rectus sheath block, ropivacaine 0.25 % - Cardiac Valve Disease, Coronary Heart Disease | Phase 4 | Not yet recruiting | Hôpital du Valais | 100 | 2026-11-01 | 2026-10-22 |
| Self-administered Subcutaneous Daratumumab in Patients With Multiple Myeloma The study intervention is self-administration of SC daratumumab by the patient, thereby changing the administration from an outpatient setting to a home setting. - Multiple Myeloma in Relapse | Phase 4 | Not yet recruiting | Odense University Hospital | 50 | 2026-11-01 | 2026-10-21 |
| Effects of Remimazolam on Postoperative Cognitive Dysfunction and Neuroinflammatory Biomarkers in Patients Undergoing Aortic Arch Surgery Remimazolam Besylate, propofol - Aortic Aneurysm of the Proximal Arch, Aortic Aneurysms Arch | Phase 4 | Not yet recruiting | Seoul National University Hospital | 80 | 2026-11-01 | 2026-10-29 |
Showing 20 of 3673. Sign in to see all of them.
Hypertension (702) · Coronary Artery Disease (644) · Stroke (231) · Acute Coronary Syndrome (227) · Myocardial Infarction (214) · Atherosclerosis (177) · Coronary Disease (159) · Diabetes Mellitus, Type 2 (154) · Ischemic Stroke (147) · Diabetes Mellitus (142) · Cardiovascular Diseases (125) · ST Elevation Myocardial Infarction (114) · Thrombosis (107) · Myocardial Ischemia (86) · Peripheral Arterial Disease (85)
Cardiovascular Diseases (3548) · Heart Diseases (1467) · Myocardial Ischemia (1284) · Pathological Conditions, Signs and Symptoms (1147) · Arterial Occlusive Diseases (905) · Arteriosclerosis (877) · Pathologic Processes (855) · Coronary Disease (642) · Nervous System Diseases (621) · Central Nervous System Diseases (553) · Brain Diseases (550) · Cerebrovascular Disorders (518) · Nutritional and Metabolic Diseases (473) · Metabolic Diseases (450)
Clopidogrel (236) · Aspirin (214) · Amlodipine (144) · Ticagrelor (142) · Atorvastatin (120) · Hydrochlorothiazide (106) · Valsartan (88) · Rosuvastatin Calcium (78) · Prasugrel Hydrochloride (74) · Rivaroxaban (73) · Saline Solution (60) · Sodium Chloride (56) · Telmisartan (52) · Ezetimibe (47) · Losartan (47)
Novartis (59) · Yonsei University (43) · Deutsches Herzzentrum Muenchen (41) · University of Florida (39) · Seoul National University Hospital (34) · Sanofi (33) · Boehringer Ingelheim (32) · Novartis Pharmaceuticals (32) · Seung-Jung Park (28) · University of Roma La Sapienza (28) · Assistance Publique - Hôpitaux de Paris (26) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (21) · Medical University of Vienna (20) · Peking Union Medical College Hospital (20) · Radboud University Medical Center (20)
United States (816) · China (488) · South Korea (316) · Italy (213) · Germany (195) · Canada (188) · France (139) · United Kingdom (134) · Spain (129) · Brazil (119) · Netherlands (117) · Japan (115) · Denmark (98) · Switzerland (95) · Belgium (79)
Adnan Kastrati, MD (29) · Seung-Jung Park, MD, PhD (17) · Dominick J Angiolillo, MD, PhD (10) · Julinda Mehilli, MD (10) · Albert Schomig, MD (8) · Albert Schoemig, MD (7) · David Antoniucci, MD (7)
PMID 35224730, PMID 40875095, PMID 42573020, PMID 25771069, PMID 32905623, PMID 36398903, PMID 38682786, PMID 19717846, PMID 19923168, PMID 22536282, PMID 23762142, PMID 27777598, PMID 36526898, PMID 38018702, PMID 11519503, PMID 12221155, PMID 16731270, PMID 17261652, PMID 21869730, PMID 22230384, PMID 22880024, PMID 23737852, PMID 24957314, PMID 25173339, PMID 25254054, PMID 28304224, PMID 29030456, PMID 32588238, PMID 34515113, PMID 35244208, PMID 11786451, PMID 15842354, PMID 16271642, PMID 17394957, PMID 17898099, PMID 17964349, PMID 18307999, PMID 18757238, PMID 18765162, PMID 18940900, PMID 19264239, PMID 19482214, PMID 19577985, PMID 19706858, PMID 19737719, PMID 20031730, PMID 20231231, PMID 20432394, PMID 20531008, PMID 20554978
2009 (20), 2014 (12), 2018 (11), 2023 (10), 2008 (8), 2025 (8), 2015 (5), 2016 (5), 2005 (4), 2017 (4), 2019 (4), 2004 (3), K23HL105897 (2), K23MH067710 (2), 1IK2CX002368-01A1 (1)